Britannia Life Sciences Inc

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2022, Britannia Life Sciences Inc has already paid €0.0296 in dividends. The last payout was in July 2022.

Financials

In the last quarter, Britannia Life Sciences Inc had revenue of €62.52K and net profit of €739.03K

(EUR)	June 2026	YoY
Revenue	62.52K	40.94%
Gross profit	11.98K	32.08%
Net profit	739.03K	271.53%
EBITDA	-211.28K	49.23%

Fundamentals

Metric	Value
Market capitalization	€7.27M
Number of shares	162.25M
52-week high/low	€0.0704 - €0.0384
Dividends	No
Beta	-0.06
P/E ratio	0.76
PEG ratio	0.01
P/B ratio	0.52
P/S ratio	27.94

Company profile

Britannia Life Sciences Inc. provides product testing, safety assessment, and compliance services to the cosmetics, nutraceutical, and consumer packaged goods industries in the United Kingdom and internationally. The company is based in Toronto, Canada.